CTS Stock Analysis: CTS | NYSE
Electronic Components | NYSE, USA | Market Cap: 1.649m USD | 12M Return: 31.6% | US1265011056 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.5M
EPS Trend: 54.5%
Qual. Beats: 2
Rev. Trend: 12.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CTS Corporation (NYSE: CTS) is a U.S.-based electronic components manufacturer specializing in sensors, connectivity components, and actuators for transportation, industrial, medical, aerospace, and defense end markets. The company operates across North America, Europe, and Asia and is classified within the Information Technology sector under the Electronic Manufacturing Services sub-industry, a segment that includes firms supplying components and assemblies to original equipment manufacturers across multiple industries. Diversified exposure across heavy-industrial and regulated end markets is a common structural feature of the sector.
CTSs product portfolio includes controls, pedals, sensors, switches, transducers, piezo sensing products, EMI/RFI filters, capacitors, resistors, RF filters, frequency control products, and piezo microactuators and rotary actuators. These items span active and passive electronic components, which together form the foundational building blocks of electronic assemblies. The company reaches customers through internal sales engineers, independent manufacturer representatives, and third-party distributors, a hybrid channel structure typical of mid-sized component suppliers. Founded in 1896 and headquartered in Lisle, Illinois, CTS has been listed on the NYSE since 1987.
- EV adoption drives automotive sensor and pedal demand
- Aerospace and defense bookings expand at higher margins
- M&A strategy broadens sensing and connectivity portfolio
| Net Income: 69.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 0.40 > 1.0 |
| NWC/Revenue: 31.27% < 20% (prev 30.95%; Δ 0.31% < -1%) |
| CFO/TA 0.14 > 3% & CFO 109.0m > Net Income 69.8m |
| Net Debt (43.0m) to EBITDA (131.9m): 0.33 < 3 |
| Current Ratio: 2.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (29.0m) vs 12m ago -3.46% < -2% |
| Gross Margin: 39.33% > 18% (prev 37.82%; Δ 1.51% > 0.5%) |
| Asset Turnover: 71.67% > 50% (prev 66.40%; Δ 5.26% > 0%) |
| Interest Coverage Ratio: 23.04 > 6 (EBIT TTM 96.8m / Interest Expense TTM 4.20m) |
| A: 0.22 (Total Current Assets 286.4m - Total Current Liabilities 109.8m) / Total Assets 791.5m |
| B: 0.94 (Retained Earnings 747.5m / Total Assets 791.5m) |
| C: 0.12 (EBIT TTM 96.8m / Avg Total Assets 788.1m) |
| D: 2.62 (Book Value of Equity 572.8m / Total Liabilities 218.7m) |
| Altman-Z'' = 8.12 = AAA |
| DSRI: 0.96 (Receivables 92.2m/88.2m, Revenue 564.8m/521.1m) |
| GMI: 0.96 (GM 37.82% / 39.33%) |
| AQI: 0.93 (AQ_t 0.49 / AQ_t-1 0.52) |
| SGI: 1.08 (Revenue 564.8m / 521.1m) |
| TATA: -0.05 (NI 69.8m - CFO 109.0m) / TA 791.5m) |
| Beneish M = -3.07 (Cap -4..+1) = AA |
As of August 25, 2026, the stock is trading at USD 56.13 with a total of 98,994 shares traded. Over the past week, the price has changed by -11.42%, over one month by -6.43%, over three months by -13.93% and over the past year by +31.61%.
Current recommended Stop Loss: 53.20 (which is 5.2% or 1.3 ATR below the current price).
CTS has no consensus analysts rating.
| Analysts Target Price | 65 | 15.8% |
P/E Trailing = 24.159
P/E Forward = 23.0947
P/S = 2.9222
P/B = 2.8805
P/EG = 1.4445
Revenue TTM = 564.8m USD
EBIT TTM = 96.8m USD
EBITDA TTM = 131.9m USD
Long Term Debt = 55.0m USD (from longTermDebt, last quarter)
Short Term Debt = 19.3m USD (from shortTermDebt, last quarter)
Debt = 150.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 34.9m
Net Debt = 43.0m USD (calculated: Debt 150.6m - CCE 107.5m)
Enterprise Value = 1.69b USD (1.65b + Debt 150.6m - CCE 107.5m)
Interest Coverage Ratio = 23.04 (Ebit TTM 96.8m / Interest Expense TTM 4.20m)
EV/FCF = 18.51x (Enterprise Value 1.69b / FCF TTM 91.4m)
FCF Yield = 5.40% (FCF TTM 91.4m / Enterprise Value 1.69b)
FCF Margin = 16.18% (FCF TTM 91.4m / Revenue TTM 564.8m)
Net Margin = 12.36% (Net Income TTM 69.8m / Revenue TTM 564.8m)
Gross Margin = 39.33% ((Revenue TTM 564.8m - Cost of Revenue TTM 342.7m) / Revenue TTM)
Gross Margin QoQ = 41.49% (prev 38.45%)
Tobins Q-Ratio = 2.14 (Enterprise Value 1.69b / Total Assets 791.5m)
Interest Expense / Debt = 2.79% (Interest Expense 4.20m / Debt 150.6m)
Taxrate = 24.62% (22.8m / 92.6m)
NOPAT = 73.0m (EBIT 96.8m * (1 - 24.62%))
Current Ratio = 2.61 (Total Current Assets 286.4m / Total Current Liabilities 109.8m)
Debt / Equity = 0.26 (Debt 150.6m / totalStockholderEquity, last quarter 572.8m)
Debt / EBITDA = 0.33 (Net Debt 43.0m / EBITDA 131.9m)
Debt / FCF = 0.47 (Net Debt 43.0m / FCF TTM 91.4m)
Total Stockholder Equity = 557.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.85% (Net Income 69.8m / Total Assets 791.5m)
RoE = 12.52% (Net Income TTM 69.8m / Total Stockholder Equity 557.4m)
RoCE = 15.80% (EBIT 96.8m / Capital Employed (Equity 557.4m + L.T.Debt 55.0m))
RoIC = 10.84% (NOPAT 73.0m / Invested Capital 672.8m)
WACC = 9.63% (E(1.65b)/V(1.80b) * Re(10.32%) + D(150.6m)/V(1.80b) * Rd(2.79%) * (1-Tc(0.25)))
Discount Rate = 10.32% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.59 | Cagr: -2.99%
[DCF] Terminal Value 71.71% ; FCFF base≈89.8m ; Y1≈93.6m ; Y5≈106.6m
[DCF] Fair Price = 45.72 (EV 1.35b - Net Debt 43.0m = Equity 1.31b / Shares 28.6m; r=9.63% [WACC]; 5y FCF grow 4.46% → 2.50% )
EPS Correlation: 54.46 | EPS CAGR: 4.17% | SUE: 2.56 | # QB: 2
Revenue Correlation: 12.83 | Revenue CAGR: 0.54% | SUE: 0.27 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.68 | Chg30d=+4.62% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=2.72 | Chg30d=+11.93% | Revisions=+25% | GrowthEPS=+22.0% | GrowthRev=+6.5%
EPS next Year (2027-12-31): EPS=2.98 | Chg30d=+3.11% | Revisions=+25% | GrowthEPS=+9.6% | GrowthRev=+6.5%